Management of Recurrent Urinary Tract Infections

Diagnosis and Treatment

Obtain a urine culture immediately before initiating any new antibiotic therapy, then switch to a first-line agent such as nitrofurantoin, trimethoprim-sulfamethoxazole, or fosfomycin based on culture susceptibilities, as recommended by the American College of Physicians and IDSA 1, 2, 3
Document positive urine cultures with each symptomatic episode to confirm true recurrent UTI rather than treatment failure or reinfection, according to the American Urological Association 4
Culture results will guide appropriate antibiotic selection based on susceptibility patterns, as suggested by the Infectious Diseases Society of America 4
The American College of Physicians and IDSA guidelines do not recommend beta-lactams as first-line therapy because data are insufficient to support their efficacy compared to nitrofurantoin, TMP-SMX, or fosfomycin 1, 2, 5

Nitrofurantoin monohydrate/macrocrystals 100 mg twice daily for 5 days is a first-line option with minimal resistance and limited collateral damage, as recommended by the American College of Physicians 1, 2, 3
Trimethoprim-sulfamethoxazole 160/800 mg (one double-strength tablet) twice daily for 3 days is a first-line option only if local resistance rates are <20%, according to the IDSA 1, 2
Fosfomycin trometamol 3 g single dose is a convenient single-dose option where available, as suggested by the European Urological Association 1, 2, 3

Do NOT routinely obtain cystoscopy or upper tract imaging in otherwise healthy women with recurrent UTI, as recommended by the American Urological Association 4
Consider further evaluation if fever or flank pain suggesting pyelonephritis, structural or functional genitourinary abnormalities on exam, immunocompromised state, diabetes, or neurological disease, according to the IDSA 1, 5, 4

Avoid treating asymptomatic bacteriuria - only treat symptomatic infections to reduce antibiotic resistance, as recommended by the Centers for Disease Control and Prevention 4
Dysuria is the central diagnostic symptom with >90% accuracy for UTI, according to the American Urological Association 4
Acute-onset dysuria with urgency/frequency indicates true infection requiring treatment, as suggested by the Infectious Diseases Society of America 4
Positive urine culture without symptoms does not require antibiotics, as recommended by the IDSA 4

The European Urology guidelines suggest that a patient can safely be prescribed Macrobid (nitrofurantoin) again 4 weeks after completing a previous course for uncomplicated UTI, as this represents a new treatment episode rather than continuous therapy 6
A standard 5-day course of nitrofurantoin is recommended for new infections with typical uncomplicated cystitis symptoms, according to the Annals of Internal Medicine and European Urology guidelines 6, 7

The European Urology guidelines recommend against prescribing nitrofurantoin if the patient has fever or flank pain suggesting pyelonephritis, as nitrofurantoin has insufficient data for upper tract infections 8
Nitrofurantoin should not be prescribed in the last trimester of pregnancy, according to the European Urology guidelines 6

The European Urology guidelines recommend obtaining a urine culture before initiating the new antibiotic course to confirm true recurrent infection versus treatment failure from the initial episode, and to determine continued susceptibility to nitrofurantoin 6

If the patient had symptoms that did not resolve or recurred within 2-4 weeks after the initial treatment, culture results should guide selection of an alternative first-line agent, such as trimethoprim-sulfamethoxazole or fosfomycin, according to the Annals of Internal Medicine guidelines 7